Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
AOD 9604 does not cause fluid retention
A.DonzelliM.SchrammY.DieuL
It exists in a regulatory gray area as a research chemical
2 way Dual Activation GHRH-R (CJC-1295) + GHS-R1a (Ipamorelin) two complementary pituitary targets 2-4x GH AUC Demonstrated Synergy Area under the GH curve 2 to 4 times greater than each peptide in monotherapy 5.8 - 8.1 days CJC-1295 Half-Life Sustained elevation of IGF-1 for 9 to 11 days after a single injection 10 mg Pre-formulated mix 5 mg CJC-1295 (No DAC) + 5 mg Ipamorelin per vial | Purity 99% HPLC Selective Hormonal Profile Ipamorelin: no increase in cortisol, prolactin or ACTH (Raun et al., 1998) Mechanism of Action Dual-Channel Synergy Simultaneous activation of GHRH-R and GHS-R1a for amplified GH stimulation GHRH Lane CJC-1295 GHRH Analog (Mod GRF 1-29) A synthetic peptide of 29 amino acids that selectively binds to the GHRH receptor on pituitary somatotroph cells
The effects of L-carnitine L-tartrate supplementation on hormonal responses to resistance exercise and recovery
US$ 24.85
US$ 24.57
US$ 24.04
US$ 21.37
US$ 20.74
US$ 28.87
US$ 25.73
US$ 22.40
US$ 26.58
US$ 23.34
US$ 21.41
